EAN NewsOther News

News from EMA – European Medicines Agency

June 5, 2020

Latest updates on COVID-19

The European Medicines Agency (EMA) is contributing to global efforts to save lives during the COVID-19 pandemic by expediting the development and approval of safe and effective treatments and vaccines, supporting the continued availability of medicines in the European Union (EU), and providing reliable information to patients and healthcare professionals.

The latest updated can be found here.

You may also like

EAN – Rare Neurological Diseases and BioPontis Alliance for Rare Diseases

December 1, 2016

Brain Health School Challenge winners honoured in special award ceremony

March 15, 2024

News from the European Research Network (ERN) – Rare Neurological Diseases (RND)

May 1, 2019

News from EMA: Booklet on EMA pre-submission and assessment processes

April 1, 2019

Scoping review of prevalence of neurologic comorbidities in patients hospitalized for COVID-19

May 6, 2020

Changes in characteristics, treatment and outcome in patients with hemorrhagic stroke during COVID-19

January 5, 2021

Breaking News: Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry

June 23, 2020

Risk of hospitalization and death for COVID‐19 in people with Parkinson’s disease or parkinsonism

December 2, 2020

Paper of the month: Endovascular Thrombectomy with or without Intravenous Alteplase in Acute Stroke

July 3, 2020

Research Paper of the month: Dementia prevention, intervention, and care: 2020 report of the Lancet Commission

October 1, 2020

Leave a Comment